In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...
Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...
Pfizer and BioNTech have been among the leaders in the race to bring a combined COVID-19 and influenza vaccine to market, but have stumbled in the final straight. The companies reported mixed ...
Findings highlight the Pfizer-BioNTech vaccine’s role in preventing MIS-C, a rare post-COVID inflammatory syndrome in ...
For the Pfizer/BioNTech and Moderna vaccines, this means that small changes were made to the mRNA in the vaccine so that the ...
The CDC recommends that immunocompromised people and those age 65 and older should get a second dose of the 2024-2025 COVID ...
The FDA already has cleared COVID-19 vaccines tweaked to better target omicron as boosters for everyone 5 and older. Pfizer's says its COVID-19 vaccine was 73% effective in protecting children ...
Health officials say it's important to get flu and COVID-19 vaccines ahead of the holidays when respiratory bugs tend to ...
Pfizer reported third-quarter revenue and adjusted profit that blew past expectations. The company hiked its full-year ...
Pfizer PFE COVID revenues have been declining due to lower demand. The company records direct sales and alliance revenues from its partner, BioNTech BNTX, for the COVID-19 vaccine, Comirnaty ...